Diclof 0.1% Guttae Ophthal. in Pediatric Ophthalmology

Overview

The authors analyze their two years experience with 208 patients hospitalized atthe Clinic of Pediatric Ophthalmology treated by the locally administered antiprostaglandin diclophenac, 0.1% eye drops. The spectrum of the disease was wideand comprised different conditions after intraocular surgery, in particular ofcataract, glaucoma and perforation injuries, Yag laser capsulotomy, and conservatively treated conditions, in particular inflammatory processes, uveitis andkeratoconjunctivitis. Diclophenac was not combined with other non-steroid antiphlogistics but frequently it wasadjuvant treatmentof corticosteroids, antibioticsand mydriatics. The authors did not observe any sideeffects of the preparation,even after long-term administration or after short-term administration to neonates. As to the intensity of effect, diclophenac was comparable with other prostag-landin inhibitors and in pediatric ophthalmology it is an effective and safeantiphlogistic agent.

Key words:
non-steroid antiphlogistics, prostaglandin inhibitors, diclophenac